Related Experiment Videos
Intention-to-treat approach to data from randomized controlled trials: a sensitivity analysis
1School of Health and Social Sciences, Coventry University, Priory Street, Coventry CV1 5FB, UK. hsx232@coventry.ac.uk
Journal of Clinical Epidemiology
|September 25, 2003
Summary
Intention-to-treat (ITT) analysis in randomized trials may bias results if participants deviate from assigned treatment. Sensitivity analyses are crucial for accurate interpretation of trial data.
Area of Science:
- Clinical Trials
- Biostatistics
- Epidemiology
Background:
- Randomized controlled trials (RCTs) commonly employ the intention-to-treat (ITT) principle, analyzing data based on initial treatment assignment.
- Alternative analytical strategies include as-treated and completers-only analyses, which consider actual treatment received or adherence to protocol.
- Protocol deviations, such as loss to follow-up and treatment switching, are common challenges in RCTs.
Purpose of the Study:
- To compare the performance of intention-to-treat (ITT) analysis against alternative approaches (as-treated, completers-only) under common protocol deviations.
- To evaluate the impact of nonrandom loss to follow-up and treatment switching on treatment effect estimates in RCTs.
- To assess the influence of deviation rates (10% and 30%) and missing data imputation methods on analytical outcomes.
Main Methods:
- A hypothetical randomized trial dataset was utilized for comparative analysis.
- Sensitivity analyses were performed to assess different analytical approaches under varying conditions of protocol deviation.
- The study simulated scenarios with 10% and 30% rates of loss to follow-up and treatment switching.
Main Results:
- Biased treatment effect estimates can arise from nonrandom deviations, substantial treatment switching, or inadequate handling of missing data.
- Intention-to-treat (ITT) analysis generally attenuates (reduces) observed between-group effects.
- The choice of method for imputing missing values significantly impacts results, especially when loss to follow-up is nonrandom.
Conclusions:
- Trialists must conduct sensitivity analyses to evaluate the robustness of their findings, particularly when protocol deviations are present.
- Comparing characteristics of participants who deviate versus those who adhere is essential for understanding potential biases.
- The intention-to-treat (ITT) approach is not a panacea for poor trial design; high-quality data collection and appropriate analysis are paramount.